top of page
New Gene linked to Down Syndrome.
Heart Gene Therapy trial begins.

The first gene therapy trial for patients with heart failure has begun in Britain. The ground-breaking research will aim to see if genetic material can be inserted into the heart and help it work better.

 

Click here for more information.

Genetic editing shows promise in DMD
Gene Therapy for Retinal Atrophies

The world of Gene Therapy is never at rest, all the time there are exciting new advances and researches that are completely out of the blue. Inorder to keep up with the research world, exciting new developments in the fields of genetic research will be posted regularly.  Have a read through!

 

Genetic cause of childhood leukaemia found
New treatment strategy for breast cancer

Scientists have identified a gene on the extra chromosome causing Down syndrome that may be responsible for the early aging and cognitive defects in people with the condition, a finding that could lead to new treatments

 

Click here for more information.

Researchers at Michigan State University (MSU) provide the first phenotypic evidence a mutated gene causes one form of progressive retinal atrophy in papillon dogs. Progressive retinal atrophy is analogous to one of the leading cause of inherited blindness in humans and the findings may lead to new treatments for blindness in humans.

 

Click here for more information.

Using a novel genetic 'editing' technique, Duke University biomedical engineers have been able to repair a defect responsible for one of the most common inherited disorders, Duchenne muscular dystrophy, in cell samples from Duchenne patients.

 

 

 

Click here for more information.

For the first time, a genetic link specific to risk of childhood leukemia has been identified, according to a team of researchers from Memorial Sloan-Kettering Cancer Center, St. Jude Children's Research Hospital, University of Washington, and other institutions.

 

Click here for more information.

Researchers at UCLA's Jonsson Comprehensive Cancer Center (JCCC) have successfully combined cellular therapy and gene therapy in a mouse model system to develop a viable treatment strategy for breast cancer that has metastasized, or spread, to the patient's brain.

 

Click here for more information.

Latest News.

  • Facebook Classic
  • Twitter Classic
  • Google Classic
  • YouTube Classic
bottom of page